Data-driven discovery of targets for bipotent anticancer drugs identifies Estrogen Related Receptor Alpha
A. Sahu, X. Wang, P. Munson, J. Klomp, X. Wang, S. Gu, G. Qian, P. Nicol, Z. Zeng, C. Wang, C. Tokheim, W. Zhang, J. Fu, J. Wang, N. Nair, , K. Flaherty
BipotentR identifies immune-metabolic regulators for bipotent anticancer drugs, demonstrating ESRRA inhibition's effects on tumor metabolism and immune mechanisms.
bioRxiv · Oct 25, 2021 · PreprintCancer Biology